Levotofisopam

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLevotofisopam
Drug Alias Namelevotofisopamum左托非索泮(S)-tofisopamS-tofisopam
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmos Corp
Active IndicationsN/A
Inactive IndicationsHyperuricemiaGout

Other Information

ATC CodeN/A
Related LinksKEGG